Physician profile
John R Hoyt
NPI 1194929182
$1,109.18
in general payments reported to CMS, 2019-2025
19 companies · $445 in 2025
The $445 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $164 · 2021: $110 · 2022: $60.45 · 2023: $137 · 2024: $89.35 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $671.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $194.82 | 2023-2025 | Amplatzer Amulet, Mini Trek, Diamondback Coronary |
| Abiomed | $176.96 | 2023-2025 | Impella |
| Boston Scientific Corporation | $139.08 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $103.40 | 2024-2025 | Camzyos, Eliquis |
| Actelion Pharmaceuticals US, INC. | $96.14 | 2020 | |
| Lantheus Medical Imaging, INC. | $64.37 | 2019 | |
| Shockwave Medical, INC | $48.59 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $41.44 | 2021-2024 | Micra |
| Novartis Pharmaceuticals Corporation | $35.38 | 2025 | |
| Pfizer INC. | $31.03 | 2019-2025 | |
| Chiesi USA, INC. | $26.72 | 2022 | |
| Philips North America LLC | $26.55 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Impulse Dynamics (USA) INC. | $25.11 | 2025 | Optimizer |
| Bayer Healthcare Pharmaceuticals INC. | $20.35 | 2025 | |
| Angiodynamics, INC. | $17.52 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $16.83 | 2020 | |
| Livanova USA, INC. | $16.70 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $14.28 | 2021 | |
| Medtronic Vascular, INC. | $13.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hoyt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.